Onglyza approved in Europe

pharmafile | October 6, 2009 | News story | Sales and Marketing |  EU, Onglyza, diabetes 

Related Content

Sharp invests $100m in US and EU manufacturing and packaging facilities

Sharp Services, a pharmaceutical packaging and sterile manufacturing specialist, has announced investments totalling $100m across …

MetP Pharma releases positive data on intranasal semaglutide administration

MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering …

Sarclisa recommended for EU approval in newly diagnosed multiple myeloma

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended Sanofi’s …

The Gateway to Local Adoption Series

Latest content